IL6 and head and neck squamous cell carcinoma: However, in a 2009 study by Dae-Young Hong et al. investigating a number of biomarkers in patients with HNSCC, no significant difference was observed between the serum levels of IL-6 in patients with malignancy compared with the control group, indicating higher specificity of this cytokine in LSCC.